|  | |  | The latest research news articles are shown below. To view older articles please visit the archive.  | ROYAL FREE HOSPITAL AND UNIVERSITY COLLEGE LONDON UNVEILED AS CENTRE OF EXCELLENCE IN BLOOD CANCER RESEARCH |
|  |  | | University College London (UCL) and the Royal Free Hospital were named as a Centre of Excellence by Leukaemia & Lymphoma Research on 8 June. The charity has £8.7 million currently invested in research projects at the Centre. It has been recognised for its world-class research into all of the main blood cancers – leukaemia, lymphoma and myeloma. | | Release date: 08 Jun 2010 |  |
|
 | University of Southampton unveiled as centre of excellence in blood cancer research |
|  |  | | The University of Southampton was named on Monday, 24 May as a Centre of Excellence by the national blood cancer charity Leukaemia & Lymphoma Research. The charity has over £7 million currently invested in research projects at the Centre. It has been recognised for its world-class research into all of the main blood cancers – leukaemia, lymphoma and myeloma. | | Release date: 24 May 2010 |  |
|
 | Cardiff University unveiled as Centre of Excellence in blood cancer research |
|  |  | | Cardiff University was today named (Tuesday, 18 May) as Leukaemia & Lymphoma Research’s first Centre of Excellence. This year alone, the national blood cancer charity has invested over £1 million in new projects at the Centre. | | Release date: 18 May 2010 |  |
|
 | Genetic testing can predict relapse in childhood cancer |
|  |  | | A study by Leukaemia & Lymphoma Research scientists at Newcastle University has shown that the presence of certain chromosomal abnormalities in leukaemic cells strongly indicate how children with leukaemia will respond to treatment. This knowledge will enable doctors to more accurately predict a child’s prognosis and adjust their treatment accordingly. | | Release date: 20 April 2010 |  |
|
 | Promising new gene therapy treatment for leukaemia is a step closer |
|  |  | | A promising new cancer treatment for patients with leukaemia has been brought a step closer after a study by Leukaemia & Lymphoma Research scientists has overcome one of the possible side effects linked with this therapy. | | Release date: 19 April 2010 |  |
|
|
|
|
|